ALVO
NASDAQ
$3.41
Alvotech (ALVO)
Alvotech Holdings SA, develops and manufactures biosimilars for global markets. The company is headquartered in Iceland.
This company is also listed under the following ticker: ALVOW.
Website: https://www.alvotech.comSector:
Healthcare
Buy
Target: $14.60 (+328.15%)
Market Cap
$1.12B
Revenue 5Y CAGR
+61.36%
FCF 5Y CAGR
+26.48%
Free Cash Flow Yield
-18.85%
Price Chart
Valuation
Market Cap$1.12B
Forward P/E7.91
P/S2.03
Profitability
Total Revenue (TTM)$559M
Gross Profit (TTM)$346M
EBITDA$52M
Profit Margin1%
Operating Margin9.1%
EPS-$0.30
Financial Health
Debt-to-Equity-516.2%
Free Cash Flow Yield-18.85%
Growth & Risk
EPS 5Y CAGR-18.97%
Revenue 5Y CAGR+61.36%
FCF 5Y CAGR+26.48%
Beta (5Y)0.79
Sharpe Ratio-0.98